Subconjunctival Bevacizumab in corneal neovascularization
Sara Maher Al Warraky;
Abstract
Our study that included 20 eyes of 20 patients with established corneal neovascularization received a single subconjunctival injection of 2.5 mg (0.1 ml) bevacizumab and morphological changes in the major and minor vessels were studied by slit-lamp biomic
Other data
| Title | Subconjunctival Bevacizumab in corneal neovascularization | Other Titles | تأثير حقن مادة الأفستن تحت الملتحمة في حالات الأوعية الدموية المستحدثة بالقرنية | Authors | Sara Maher Al Warraky | Keywords | Subconjunctival Bevacizumab in corneal neovascularization | Issue Date | 2014 | Description | Our study that included 20 eyes of 20 patients with established corneal neovascularization received a single subconjunctival injection of 2.5 mg (0.1 ml) bevacizumab and morphological changes in the major and minor vessels were studied by slit-lamp biomic |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 119846R9188.pdf | 384.49 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.